| http://www.w3.org/ns/prov#value | - Advise the patient that liver function tests may be monitored during treatment. 17.2 Hypersensitivity Inform the patient that anaphylactic reactions, including shock were reported with ERAXIS. Inform the patient if these reactions occur, ERAXIS may be discontinued and appropriate treatment administered.
|
